Find Federal Grants
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-107
National Institutes of Health · PAR-25-106
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-235
Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
National Institutes of Health · PAS-25-190
National Institutes of Health · PAR-25-083
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-186
National Institutes of Health · PAR-25-082
National Institutes of Health · PAR-25-135
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · PAR-25-052
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-217
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-220
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-26-034
Health Resources and Services Administration · HRSA-25-026
National Institutes of Health · PAR-25-129
National Institutes of Health · PAR-25-128
National Institutes of Health · RFA-HG-25-004
National Institutes of Health · RFA-HG-25-003
National Institutes of Health · RFA-HG-25-002
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-275
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
National Institutes of Health · RFA-HL-26-015